Contributor Perspectives

Is China Effectively Reforming Its Biotechnology Laws?

Edward Perello
Board of Contributors
Dec 6, 2019 | 11:00 GMT
This Dec. 26, 2018, photo shows a researcher working in a Beijing Genomics Institute laboratory in Kunming, China.

A researcher works in a Beijing Genomics Institute laboratory in Kunming, China, on Dec. 26, 2018. China has publicized a series of new regulations since a Chinese scientist claimed to have genetically engineered twins last year, but has not accounted for the scientist's alleged feat.

(Visual China Group via Getty Images)

Since news broke in late November 2018 that Chinese scientist He Jiankui had used the gene-editing tool CRISPR to engineer twins to ensure heritable immunity to HIV, Beijing has implemented a multitiered response to address apparent shortcomings in Chinese laws. New regulations governing the protection and use of human genes, patients and embryos in preclinical and clinical research are coming into force, but do they mean real change for the country?...

Connected Content

Regions & Countries
Companies

Article Search

Copyright © Stratfor Enterprises, LLC. All rights reserved.

Stratfor Worldview

OUR COMMITMENT

To empower members to confidently understand and navigate a continuously changing and complex global environment.